Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis

Nephrology Dialysis Transplantation

Volumn 29, Issue 1, 2014, Pages 41-48

  Lorenz, Georg ^a   Darisipudi, Murthy N ^a   Anders, Hans Joachim ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

crystal nephropathy; dendritic cells; glomerulonephritis; macrophages; tubular injury

Indexed keywords

CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; TRANSFORMING GROWTH FACTOR BETA;

ACUTE KIDNEY FAILURE; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY FIBROSIS; KIDNEY INFECTION; KIDNEY INJURY; MOLECULAR PATHOLOGY; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

CRYSTAL NEPHROPATHY; DENDRITIC CELLS; GLOMERULONEPHRITIS; MACROPHAGES; TUBULAR INJURY;

ANIMALS; APOPTOSIS; CARRIER PROTEINS; CASPASE 1; CYTOKINES; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROSIS; HUMANS; INFLAMMASOMES; INFLAMMATION; INTERLEUKIN-18; INTERLEUKIN-1BETA; KIDNEY; KIDNEY DISEASES; URINARY TRACT INFECTIONS;

EID: 84892754061     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft332     Document Type: Review

References (63)

1. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008; 454: 428-435
2. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140: 805-820
3. Schroder K, Tschopp J. The inflammasomes. Cell 2010; 140: 821-832
4. Sancho D, Reis e Sousa C. Signaling by myeloid C-type lectin receptors in immunity and homeostasis. Annu Rev Immunol 2012; 30: 491-529
5. Lech M, Avila-Ferrufino A, Skuginna V et al. Quantitative expression of RIG-like helicase, NOD-like receptor and inflamma-some-related mRNAs in humans and mice. Int Immunol 2010; 22: 717-728
6. Rock KL, Latz E, Ontiveros F et al. The sterile inflammatory response. Ann Rev Immunol 2010; 28: 321-342
7. Anders HJ, Banas B, Schlondorff D. Signaling danger: toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol 2004; 15: 854-867
8. Anders HJ, Muruve DA. The inflammasomes in kidney disease. J Am Soc Nephrol 2011; 22: 1007-1018
9. Lamkanfi M, Dixit VM. Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol 2012; 28: 137-161
10. Tian X, Pascal G, Monget P. Evolution and functional divergence of NLRP genes in mammalian reproductive systems. BMC Evol Biol 2009; 9: 202
11. Rathinam VA, Vanaja SK, Fitzgerald KA. Regulation of inflam-masome signaling. Nat Immunol 2012; 13: 333-332
12. Kanneganti TD, Lamkanfi M, Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity, 2007; 27: 549-559
13. Kayagaki N, Warming S, Lamkanfi M et al. Non-canonical inflammasome activation targets caspase-11. Nature, 2011; 479: 117-121
14. Jin C, Flavell RA. Molecular mechanism of NLRP3 inflammasome activation. J Clin Immunol, 2010; 30: 628-631
15. Hornung V, Bauernfeind F, Halle A et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through pha-gosomal destabilization. Nat Immunol 2008; 9: 847-856
16. Darisipudi MN, Allam R, Rupanagudi KV et al. Polyene macro-lide antifungal drugs trigger interleukin-1beta secretion by activating the NLRP3 inflammasome. PLoS One 2011; 6: e19588
17. Allam R, Darisipudi MN, Rupanagudi KV et al. Cutting edge: cyclic polypeptide and aminoglycoside antibiotics trigger IL-1beta secretion by activating the NLRP3 inflammasome. J Immunol 2011; 186: 2714-2718
18. Darisipudi MN, Thomasova D, Mulay SR et al. Uromodulin triggers IL-1beta-dependent innate immunity via the NLRP3 inflammasome. J Am Soc Nephrol 2012; 23: 1783-1789
19. Mulay SR, Kulkarni OP, Rupanagudi KV et al. Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1beta secretion. J Clin Invest 2013; 123: 236-246
20. Lichtnekert J, Kulkarnit OP, Mulay SR et al. Anti-GBM glomeru-lonephritis involves IL-1 but is independent of NLRP3/ASC inflammasome-mediated activation of caspase-1. PLoS One 2011; 6: e26778
21. Faust J, Menke J, Kriegsmann J et al. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis. Arthritis Rheum 2002; 46: 3083-3095
22. VanderBrink BA, Asanuma H, Hile K et al. Interleukin-18 stimulates a positive feedback loop during renal obstruction via interleu-kin-18 receptor. J Urol 2011; 186: 1502-1508
23. Franke EI, Vanderbrink BA, Hile K et al. Renal IL-18 production is macrophage independent during obstructive injury. PLoS One 2012; 7: e47417
24. Zhang C, Boini KM, Xia M et al. Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia. Hypertension 2012; 60: 154-162
25. Wang C, Pan Y, Zhang QY et al. Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation. PLoS One 2012; 7: e38285
26. Tsai PY, Ka SM, Chang JM et al. Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation. Free Radic Biol Med 2011; 51: 744-754
27. Hu QH, Zhang X, Pan Y et al. Allopurinol, quercetin and rutin ameliorate renal NLRP3 inflammasome activation and lipid accumulation in fructose-fed rats. Biochem Pharmacol 2012; 84: 113-125
28. Timoshanko JR, Kitching AR, Inakura Y et al. Leukocyte-derived interleukin-1beta interacts with renal interleukin-1 receptor I to promote renal tumor necrosis factor and glomerular injury in murine crescentic glomerulonephritis. Am J Pathol 2004; 164: 1967-1977
29. Tipping PG, Lowe MG, Holdsworth SR. Glomerular interleukin 1 production is dependent on macrophage infiltration in anti-GBM glomerulonephritis. Kidney Int 1991; 39: 103-110
30. Lacroix-Lamande S, d'Andon MF, Michel E et al. Downregulation of the Na/K-ATPase pump by leptospiral glycolipoprotein activates the NLRP3 inflammasome. J Immunol 2012; 188: 2805-2814
31. Ribeiro A, Wörnle M, Motamedi N et al. Activation of innate immune defense mechanisms contributes to polyomavirus BK-associated nephropathy. Kidney Int 2012; 81: 100-111
32. van de Veerdonk FL, Joosten LA, Shaw PJ et al. The inflamma-some drives protective Th1 and Th17 cellular responses in disseminated candidiasis. Eur J Immunol 2011; 41: 2260-2268
33. Iyer SS, Pulskens WB, Sadler JJ et al. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci USA 2009; 106: 20388-20393
34. Mulay SR, Evan A, Anders HJ. Molecular mechanisms of crystal-related kidney inflammation and injury. Implications for cholesterol embolism, crystalline nephropathies and kidney stone disease. Nephrol Dial Transplant 2013; 28: (in press)
35. Martinon F, Pétrilli V, Mayor A et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006; 440: 237-241
36. Correa-Costa M, Braga TT, Semedo P et al. Pivotal role of toll-like receptors 2 and 4, its adaptor molecule MyD88, and inflamma-some complex in experimental tubule-interstitial nephritis. PLoS One 2011; 6: e29004
37. Babelova A, Moreth K, Tsalastra-Greul W et al. Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem 2009; 284: 24035-24048
38. Saemann MD, Weichhart T, Zeyda M et al. Tamm-Horsfall glyco-protein links innate immune cell activation with adaptive immunity via a toll-like receptor-4-dependent mechanism. J Clin Invest 2005; 115: 468-475
39. Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 2011; 121: 4210-4221
40. Shigeoka AA, Mueller JL, Kambo A et al. An inflammasome-in-dependent role for epithelial-expressed Nlrp3 in renal ischemia-re-perfusion injury. J Immunol 2010; 185: 6277-6285
41. Haq M, Norman J, Saba SR et al. Role of IL-1 in renal ischemic re-perfusion injury. J Am Soc Nephrol 1998; 9: 614-619
42. Wu H, Craft ML, Wang P et al. IL-18 contributes to renal damage after ischemia-reperfusion. J Am Soc Nephrol 2008; 19: 2331-2341
43. Daemen MA, van't Veer C, Wolfs TG et al. Ischemia/reperfusion-induced IFN-gamma up-regulation: involvement of IL-12 and IL-18. J Immunol 1999; 162: 5506-5510
44. Vilaysane A, Chun J, Seamone ME et al. The NLRP3 inflamma-some promotes renal inflammation and contributes to CKD. J Am Soc Nephrol 2010; 21: 1732-1744
45. Bani-Hani AH, Leslie JA, Asanuma H et al. IL-18 neutralization ameliorates obstruction-induced epithelial-mesenchymal transition and renal fibrosis. Kidney Int 2009; 76: 500-511
46. Fan JM, Huang XR, Ng YY et al. Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro. Am J Kidney Dis 2001; 37: 820-831
47. Wang W, Wang X, Chun J et al. Inflammasome-Independent NLRP3 augments TGF-beta signaling in kidney epithelium. J Immunol 2013; 190: 1239-1249
48. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-1428
49. Kriz W, Kaissling B, Le Hir M. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?. J Clin Invest 2011; 121: 468-474
50. Lech M, Lorenz G, Kulkarni O et al. The inflammasome-related molecules NLRP3 and ASC suppress lupus nephritis of C57Bl/6lpr/lpr mice. Nephrol Dial Transplant 2013; 28: p. Congress Abstract MO055
51. Allen IC, Scull MA, Moore CB et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 2009; 30: 556-565
52. Harder J, Franchi L, Muñoz-Planillo R et al. Activation of the Nlrp3 inflammasome by Streptococcus pyogenes requires streptolysin O and NF-kappa B activation but proceeds independently of TLR signaling and P2X7 receptor. J Immunol 2009; 183: 5823-5829
53. Craven RR, Gao X, Allen IC et al. Staphylococcus aureus alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells. PLoS One 2009; 4: e7446
54. Mariathasan S, Weiss DS, Newton K et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 2006; 440: 228-232
55. Allam R, Scherbaum CR, Darisipudi MN et al. Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol 2012; 23: 1375-1388
56. Shin MS, Kang Y, Lee N et al. U1-small nuclear ribonucleoprotein activates the NLRP3 inflammasome in human monocytes. J Immunol 2012; 188: 4769-4775
57. Shin MS, Kang Y, Lee N et al. Self double-stranded (ds)DNA induces IL-1beta production from human monocytes by activating NLRP3 inflammasome in the presence of anti-dsDNA antibodies. J Immunol 2013; 190: 1407-1415
58. Riteau N, Baron L, Villeret B et al. ATP Release and purinergic signaling: a common pathway for particle-mediated inflamma-some activation. Cell Death Dis 2012; 3: e403
59. Dostert C, Pétrilli V, Van Bruggen R et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 2008; 320: 674-677.
60. Cassel SL, Eisenbarth SC, Iyer SS et al. The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci USA, 2008; 105: 9035-9040
61. Halle A, Hornung V, Petzold GC et al. The NALP3 inflamma-some is involved in the innate immune response to amyloid-beta. Nat Immunol 2008; 9: 857-865
62. Shio MT, Eisenbarth SC, Savaria M et al. Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases. PLoS Pathog 2009; 5: e1000559
63. Yamasaki K, Muto J, Taylor KR et al. NLRP3/cryopyrin Is necessary for interleukin-1beta (IL-1beta) release in response to hyaluro-nan, an endogenous trigger of inflammation in response to injury. J Biol Chem 2009; 284: 12762-12771